Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.
about
Combined hepatocellular cholangiocarcinoma: Controversies to be addressedNoninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining IssuesImaging findings of mimickers of hepatocellular carcinomaA massive hepatic tumor demonstrating hepatocellular, cholangiocarcinoma and neuroendocrine lineages: A case report and review of the literature.Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.Lymphoepithelioma-like cholangiocarcinoma: a mimic of hepatocellular carcinoma on imaging featuresIntrahepatic cholangiocarcinoma: expert consensus statement.Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.Pseudolymphoma (reactive lymphoid hyperplasia) of the liver: A clinical challengeLong-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database.A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma.Uncommon liver tumors: Case report and literature review.MRI of cholangiocarcinoma.Biphenotypic hepatic tumors: imaging findings and review of literature.Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.Imaging spectrum of cholangiocarcinoma: role in diagnosis, staging, and posttreatment evaluation.Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma.Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review.Combined hepatocellular-cholangiocarcinoma: Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis.Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management.Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.Biphenotypic Primary Liver Carcinomas: Assessing Outcomes of Hepatic Directed Therapy.Composite liver tumors: a radiologic-pathologic correlation.Magnetic Resonance Imaging of Primary Hepatic Malignancies in Patients With and Without Chronic Liver Disease: A Pictorial Review.LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma.MRI features of primary rare malignancies of the liver: A report from four university centres.Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI.Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study.Primary biliary cholangitis metachronously complicated with combined hepatocellular carcinoma-cholangiocellular carcinoma and hepatocellular carcinoma.Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.Esophageal metastasis of stem cell-subtype hepatocholangiocarcinoma: Rare presentation of a rare tumor.Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma.Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series.MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.MR comparative study of combined hepatocellular-cholangiocarcinoma in normal, fibrotic, and cirrhotic livers.Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis.The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
P2860
Q26749446-70DD3A4E-94EF-4085-803C-C699D2E5AA35Q26770020-3EF7C931-EB15-4712-A185-D9B75AC49C85Q26771777-B8CC9291-637A-4B3B-B321-D579B149F72BQ33810780-4B0A6DCE-BF81-432D-87A6-A24A1E1986C1Q34975197-03D71183-50B6-499A-82BD-48838AE30200Q35270630-9031C065-84B8-490A-A1A0-444F2BD854A7Q35924971-75D7B8C2-B12D-445C-83D7-54E522E5A28AQ35936570-2FB22652-D873-47AB-8E37-4E46AC11BC83Q36297092-136F48AB-1E85-4E8C-B361-9656289A9293Q36570284-1D85E240-3544-4642-81B8-84909F08D5F3Q37131701-5777CC50-2592-4FA2-B5F1-482966832D29Q37605862-54F7ABB8-4667-41E4-9257-F4BF56A7F4A7Q38275161-D9F56AA6-4332-4682-B39B-09428361E9CEQ38465673-DDB3E2C9-5830-4F76-B364-70BF59671E8BQ38647654-ADB861C4-DCCA-42C7-9309-6E1BAD521480Q38723527-7F46E5CE-0CD4-475E-A148-A7AECEF69A6FQ38825699-3F8D1682-5BB4-4DA2-9393-0CC8260E55FDQ38998297-CB0D2D8F-0854-4481-98A9-F431BC2F8759Q39016627-0044FAE9-2A6D-4ACA-A516-594AEF661359Q39167413-E38637EB-4D1B-4D4F-AED0-A385701526BAQ39259950-CD4BCEF1-5C86-40EE-91F0-275C810CB87FQ40621862-9B899631-343F-4A36-80B2-2D5699A4FD3BQ42132430-8FD2F0C6-046A-4268-BCC1-6FCA06DA7890Q42278259-E170203B-CD93-4ABE-A689-97650B0C1060Q44796084-2C3E9446-C299-4CB4-832D-D71803C76CC7Q46434821-ED15E6D6-5107-44A9-AA6F-6A5205AC5DA1Q47326179-30EBE24B-4B36-40B5-91B8-794B716C259FQ47423452-5ADF577A-5F14-444F-BE3F-330B62D9C61BQ47550101-5873DD89-7894-4DE0-9F08-85E839FF7BE8Q48156461-088F0696-E0FA-4792-9A6E-552BE2007A5AQ50300185-743C6D87-842B-4A41-8EBB-55848C9A0FA5Q51625972-46AC56BF-E890-4F0C-9BB1-A3E2D8A15EA9Q51827189-5FC75E40-A1F0-43DA-9CBE-9A200BB47CDAQ52682691-BCFC1381-CD58-4426-953B-7F8D7B1EE425Q53082982-A8489503-678A-4FA9-978A-C60E36CD1052Q54247807-D5E1C9F2-59FD-4890-9941-56EFE35E897EQ55100898-0902AE96-0703-4458-848B-5D8570BB2B2E
P2860
Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Combined hepatocellular and ch ...... contrast-enhanced CT and MRI.
@en
type
label
Combined hepatocellular and ch ...... contrast-enhanced CT and MRI.
@en
prefLabel
Combined hepatocellular and ch ...... contrast-enhanced CT and MRI.
@en
P2093
P356
P1476
Combined hepatocellular and ch ...... f contrast-enhanced CT and MRI
@en
P2093
Arman Sheybani
Christine O Menias
Elizabeth M Brunt
Rex A Parker
Sean Doherty
William C Chapman
P304
P356
10.2214/AJR.12.9488
P407
P577
2013-08-01T00:00:00Z